BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33042985)

  • 1. Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.
    Barth DA; Drula R; Ott L; Fabris L; Slaby O; Calin GA; Pichler M
    Front Cell Dev Biol; 2020; 8():828. PubMed ID: 33042985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.
    Barth DA; Slaby O; Klec C; Juracek J; Drula R; Calin GA; Pichler M
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31627266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring.
    Crocetto F; Falcone A; Mirto BF; Sicignano E; Pagano G; Dinacci F; Varriale D; Machiella F; Giampaglia G; Calogero A; Varlese F; Balsamo R; Trama F; Sciarra A; Del Giudice F; Busetto GM; Ferro M; Lucarelli G; Lasorsa F; Imbimbo C; Barone B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.
    Ellinger J; Gevensleben H; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1059-1065. PubMed ID: 27649770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA and Other Non-Coding RNAs as Promising Diagnostic Markers.
    Trzybulska D; Vergadi E; Tsatsanis C
    EJIFCC; 2018 Nov; 29(3):221-226. PubMed ID: 30479608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 8. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.
    E S; Costa MC; Kurc S; Drożdż A; Cortez-Dias N; Enguita FJ
    Acta Pharmacol Sin; 2018 Jul; 39(7):1085-1099. PubMed ID: 29877319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNAs as promising biomarkers in cancer.
    Beylerli O; Gareev I; Sufianov A; Ilyasova T; Guang Y
    Noncoding RNA Res; 2022 Jun; 7(2):66-70. PubMed ID: 35310927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
    Teixeira AL; Dias F; Gomes M; Fernandes M; Medeiros R
    J Kidney Cancer VHL; 2014; 1(8):84-98. PubMed ID: 28326253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma.
    Moonmuang S; Chaiyawat P; Jantrapirom S; Pruksakorn D; Lo Piccolo L
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
    de Gonzalo-Calvo D; Vea A; Bär C; Fiedler J; Couch LS; Brotons C; Llorente-Cortes V; Thum T
    Eur Heart J; 2019 May; 40(20):1643-1650. PubMed ID: 29688487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of circulating non-coding RNAs - an update.
    Anfossi S; Babayan A; Pantel K; Calin GA
    Nat Rev Clin Oncol; 2018 Sep; 15(9):541-563. PubMed ID: 29784926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
    Toraih EA; Alghamdi SA; El-Wazir A; Hosny MM; Hussein MH; Khashana MS; Fawzy MS
    PLoS One; 2018; 13(10):e0198231. PubMed ID: 30289954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal Non-coding RNAs-Mediated Crosstalk in the Tumor Microenvironment.
    Chen Q; Li Y; Liu Y; Xu W; Zhu X
    Front Cell Dev Biol; 2021; 9():646864. PubMed ID: 33912560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
    Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
    Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests.
    Kubiliute R; Jarmalaite S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers.
    Mastrolia I; Catani V; Oltrecolli M; Pipitone S; Vitale MG; Masciale V; Chiavelli C; Bortolotti CA; Nasso C; Grisendi G; Sabbatini R; Dominici M
    Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.